Cancer clinical trials in the region Auvergne-Rhône-Alpes
466 currently recruiting clinical trials
Looking for clinical trials?
Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:
- Create your account
- Copy-paste your latest medical report
- Our AI-based assistant does the rest for you
Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:
Phase 2
Lung cancer
#NCT05967689
#2023-503865-48-00
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
EGFR
None
Systemic Treatment-Naive
10 recruiting sites
Taiho Oncology
Phase 2
Lung cancer
#NCT05967689
#2023-503865-48-00
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
EGFR
None
Systemic Treatment-Naive
Systemic Treatment-Naive
10 recruiting sites
Taiho Oncology
Phase 2
Lymphoma
#NCT06558604
#2023-506706-40-00
B cell lymphoma
Mantel cell lymphoma
Early (stage I and II)
Disseminated (stage III and IV)
None
> 60 ml/min
50-60 ml/min
30-50 ml/min
None
Systemic Treatment-Naive
Bispecific T-cell engager antibodies
13 recruiting sites
The Lymphoma Academic Research Organisation (LYSARC)
Phase 2
Lymphoma
#NCT06931652
#2023-505834-84-00
B cell lymphoma
Primary cerebral lymphoma
Actives
> 60 ml/min
50-60 ml/min
30-50 ml/min
1
2
3 or more
Chemotherapy
Systemic Treatment-Naive
Bispecific T-cell engager antibodies
Allogeneic stem cell transplant
6 recruiting sites
The Lymphoma Academic Research Organisation (LYSARC)
Phase 2
Lymphoma
#NCT06558604
#2023-506706-40-00
B cell lymphoma
Mantel cell lymphoma
Early (stage I and II)
Disseminated (stage III and IV)
None
> 60 ml/min
50-60 ml/min
30-50 ml/min
1
Chemotherapy
Targeted therapy
Bispecific T-cell engager antibodies
13 recruiting sites
The Lymphoma Academic Research Organisation (LYSARC)
Phase 2
Lymphoma
#NCT06558604
#2023-506706-40-00
B cell lymphoma
Mantel cell lymphoma
Early (stage I and II)
Disseminated (stage III and IV)
None
> 60 ml/min
50-60 ml/min
30-50 ml/min
1
2
3 or more
Targeted therapy
Bispecific T-cell engager antibodies
13 recruiting sites
The Lymphoma Academic Research Organisation (LYSARC)
Phase 2
Colon cancer
Rectal cancer
#NCT07150403
#2025-522108-26-00
Adenocarcinoma
Metastatic
1
Chemotherapy
Targeted therapy
MSI/dMMR
Systemic Treatment-Naive
9 recruiting sites
Fédération Francophone de Cancérologie Digestive
Phase 2
Ovarian / Fallopian tubes / Peritoneum cancer
#NCT04602377
#2024-515310-40-01
Other ovarian cancer
Localized
Locally Advanced
Metastatic
None
Systemic Treatment-Naive
Systemic Treatment-Naive
Immunotherapy
Chemotherapy
Immunotherapy
Chemotherapy
6 recruiting sites
ARCAGY/ GINECO GROUP
Phase 2
Ovarian / Fallopian tubes / Peritoneum cancer
#NCT06690775
#2024-517190-24-00
Epithelial ovarian cancer
Fallopian tube cancer
Primary peritoneal cancer (PPC)
Serous high grade carcinoma (HGSOC)
Endometrioid carcinoma
Locally Advanced
Metastatic
Other mutation
1
2
3 or more
Recurrence within 6 months after platinum-based tr...
Chemotherapy
Systemic Treatment-Naive
3 recruiting sites
TORL Biotherapeutics, LLC
Phase 2
Ovarian / Fallopian tubes / Peritoneum cancer
#NCT05872204
Epithelial ovarian cancer
Fallopian tube cancer
Primary peritoneal cancer (PPC)
Other ovarian cancer
Serous low grade carcinoma (LGSOC)
Endometrioid carcinoma
Stromal cells and sex cords tumor
HR Positive
Locally Advanced
Metastatic
1
2
3 or more
Chemotherapy
Hormone therapy
Systemic Treatment-Naive
6 recruiting sites
Universitaire Ziekenhuizen KU Leuven